336 results
424B3
HRTX
Heron Therapeutics Inc
5 Sep 23
Prospectus supplement
9:14pm
, an independent registered public accounting firm, has audited our consolidated financial statements as of and for the periods ended December 31, 2022
8-K
EX-10.1
vx4 afmcputsulyo
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
S-8
qpk2q7flcw3a1u2yk
30 Jun 23
Registration of securities for employees
4:06pm
S-8
EX-99.1
webjog6lb72m5hk4
30 Jun 23
Registration of securities for employees
4:06pm
S-8
EX-23.2
015ckddcs7l93pufoo
30 Jun 23
Registration of securities for employees
4:06pm
8-K
uw5121gha7ckfqngd
12 Jun 23
Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer
9:10am
8-K
EX-99.1
7hsjehvca 48xk
3 Apr 23
Heron Therapeutics Announces New CEO and Board Chairman
9:10am